Complement Factor H
Showing 1 - 25 of >10,000
Age-Related Macular Degeneration Trial in Vienna (the polymerase chain reaction (PCR))
Recruiting
- Age-Related Macular Degeneration
- the polymerase chain reaction (PCR)
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Apr 6, 2022
Periodontal Diseases Trial in Chennai (Non surgical periodontal therapy)
Not yet recruiting
- Periodontal Diseases
- Non surgical periodontal therapy
-
Chennai, Tamilnadu, India
- +1 more
Apr 26, 2023
Identify Patients With Complement Factor I Deficiencies
Terminated
- Previous Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I Deficiency
-
Huntsville, AlabamaNephrology Consultants, LLC
Mar 31, 2022
Assess Clinical Outcomes of Complement Factor I
Terminated
- Recurrent Bacterial Infection, Autoimmune Disorder
- Natural History Observation
-
Huntsville, AlabamaNephrology Consultants, LLC
Mar 31, 2022
Preeclampsia, Severe Preeclampsia, Eculizumab Trial in Los Angeles (Eculizumab)
Suspended
- Preeclampsia
- +11 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jun 16, 2022
Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)
Not yet recruiting
- Acute Myeloid Leukemia
- Myeloid Neoplasm
- Biospecimen Collection
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 5, 2023
Hemophilia A Trial in Tianjin (Single dose intravenous injection of BBM-H803)
Recruiting
- Hemophilia A
- Single dose intravenous injection of BBM-H803
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital Chinese Academ
Oct 31, 2023
Chronic Pain, Musculoskeletal Pain Trial in Madrid (Pain neuroscience grupal education)
Recruiting
- Chronic Pain
- Musculoskeletal Pain
- Pain neuroscience grupal education
-
Madrid, SpainSilvia Di Bonaventura
Feb 18, 2023
Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 10, 2022
Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,
Recruiting
- Breast Ductal Carcinoma In Situ
- Granulocyte-Macrophage Colony-Stimulating Factor
- +2 more
-
Jacksonville, Florida
- +1 more
Dec 10, 2021
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Cladribine
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 18, 2022
Meningococcal Vaccines, Meningococcal Infections, Neisseria Meningitidis Trial in Oxford (4CMenB (Bexsero®) - Novartis Vaccines
Completed
- Meningococcal Vaccines
- +3 more
- 4CMenB (Bexsero®) - Novartis Vaccines and Diagnostics
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine (CCVTM)
Oct 26, 2021
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Biospecimen Collection
- +8 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 27, 2023
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +9 more
- Atezolizumab
- +12 more
- (no location specified)
Apr 26, 2023
Warts Trial in Zagazig (Candida antigen)
Completed
- Warts
- Candida antigen
-
Zagazig, Sharqia, EgyptZagazig University Faculty of Medicine
May 24, 2020
Eating Behavior Trial in Montréal (Education - Motivational factor)
Recruiting
- Eating Behavior
- Education - Motivational factor
-
Montréal, Quebec, CanadaMcGill University
Jan 24, 2023
Cardiovascular Diseases, Cardiovascular Risk Factor, Diabetes Trial in Montréal (Cardiovascular Health Awareness Program)
Active, not recruiting
- Cardiovascular Diseases
- +2 more
- Cardiovascular Health Awareness Program
-
Montréal, Quebec, CanadaCentre de recherche du CHUM
Aug 29, 2022
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)
Completed
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 23, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 12, 2023
Renal Failure, Renal Insufficiency, Renal Disease Trial (H-Guard)
Not yet recruiting
- Renal Failure
- +2 more
- H-Guard
- (no location specified)
Oct 4, 2023
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +5 more
- Biospecimen Collection
- +9 more
-
Scottsdale, Arizona
- +2 more
Oct 11, 2023